Enfermedades Crónicas y Envejecimiento

Lineas de Investigación

01. Enfermedades crónicas cardiovasculares
02. Calidad y evaluación de resultados asistenciales en enfermedades crónicas y envejecimiento
03. Enfermedades infecciosas

PROVIDE – Prediction and prevention of cardiovascular diseases in pre-diabetes and diabetes

JOSÉ JAVIER GARCÍA ALEGRÍA – UNIÓN EUROPEA – COMISIÓN EUROPEA – 2023

PI20/00783 Efectividad de la asistencia sanitaria a los pacientes con Insuficiencia Cardiaca utilizando datos del mundo real

RAUL QUIROS LÓPEZ – NACIONAL – INSTITUTO DE SALUD CARLOS III – 2020

No hay resultados

Coronavirus disease 2019 hospitalization outcomes in persons with and without HIV in Spain

Olalla-Sierra, J; Martin-Escalante, MD; Garcia-Alegria, J; Rubio-Rivas, M; de Miguel-Campo, B; Zurita-Etayo, M; Arbones-Fernandez, L; Alcala-Pedrajas, JN; Roldan-Silvestre, A; Cortes-Rodriguez, B; Casas-Rojo, JM; Nunez-Cortes, JM – 2022

Predictors of short-term COPD readmission

Quintana, JM; Anton-Ladislao, A; Orive, M; Aramburu, A; Iriberri, M; Sanchez, R; Jimenez-Puente, A; de-Miguel-Diez, J; Esteban, C – 2022

Sun Exposure and Photoprotection: Habits, Knowledge and Attitudes Among Elite Kitesurfers

Maqueda, GD; Gutierrez-Manzanedo, JV; Gonzalez-Montesinos, JL; Pardal, CV; Ruiz, FR; Martin, MD – 2022

Sun exposure and protection habits in transplant athletes: an international survey_

Navarrete-De Galvez, M; Sanchez, JMR; Navarrete-De Galvez, E; Aguilera, J; Rivas-Ruiz, F; de Troya-Martin, M; Herrera-Ceballos, E; de Galvez, MV – 2022

Sun Protection Behaviour and Sunburns in Spanish Cyclists_

Molinero, DD; Paulano, MR; Ruiz, FR; Sanchez, NB; Aranda, MVD; Maqueda, GD; Martin, MD – 2022

Ampicillin Plus Ceftriaxone Combined Therapy for Enterococcus faecalis Infective Endocarditis in OPAT_

Herrera-Hidalgo, L; Lomas-Cabezas, JM; Lopez-Cortes, LE; Luque-Marquez, R; Lopez-Cortes, LF; Martinez-Marcos, FJ; de la Torre-Lima, J; Plata-Ciezar, A; Hidalgo-Tenorio, C; Garcia-Lopez, MV; Vinuesa, D; Gutierrez-Valencia, A; Gil-Navarro, MV; De Alarcon, A – 2022

Development and evaluation of a machine learning-based in-hospital COVID-19 disease outcome predictor (CODOP): A multicontinental retrospective study_

Klen, R; Purohit, D; Gomez-Huelgas, R; Casas-Rojo, JM; Anton-Santos, JM; Nunez-Cortes, JM; Lumbreras, C; Ramos-Rincon, JM; Barrio, NG; Pedrera-Jimenez, M; Blanco, AL; Martin-Escalante, MD; Rivas-Ruiz, F; Onieva-Garcia, MA; Young, P; Ramirez, JI; Omonte, EET; Artega, RG; Beltran, MTC; Valdez, PR; Pugliese, F; Castagna, R; Huespe, IA; Boietti, B; Pollan, JA; Funke, N; Leiding, B; Gomez-Varela, D – 2022

Quality of Life During Treatment for Cervicofacial Non-melanoma Skin Cancer_

Garcia-Montero, P; de Galvez-Aranda, MV; Blazquez-Sanchez, N; Rivas-Ruiz, F; Millan-Cayetano, JF; Garcia-Harana, C; Martin, MD – 2022

Differences between Clinical Protocols for the Treatment of Coronavirus Disease 2019 (COVID-19) in Andalusia, Spain_

Perez-Belmonte, LM; Lopez-Carmona, MD; Quevedo-Marin, JL; Ricci, M; Martin-Carmona, J; Sanz-Canovas, J; Lopez-Sampalo, A; Martin-Escalante, MD; Bernal-Lopez, MR; Gomez-Huelgas, R – 2022

Influence of depression on survival of colorectal cancer patients drawn from a large prospective cohort._

Varela-Moreno, E; Rivas-Ruiz, F; Padilla-Ruiz, M; Alcaide-Garcia, J; Zarcos-Pedrinaci, I; Tellez, T; Fernandez-de Larrea-Baz, N; Bare, M; Bilbao, A; Sarasqueta, C; Morales-Suarez-Varela, MM; Aguirre, U; Quintana, JM; Redondo, M – 2022

Differences in clinical features and mortality in very old unvaccinated patients (>= 80 years) hospitalized with COVID-19 during the first and successive waves from the multicenter SEMI-COVID-19 Registry (Spain)_

Ramos-Rincon, JM; Cobos-Palacios, L; Lopez-Sampalo, A; Ricci, M; Rubio-Rivas, M; Nunez-Rodriguez, MV; Miranda-Godoy, R; Garcia-Leoni, ME; Fernandez-Madera-Martinez, R; Garcia-Garcia, GM; Beato-Perez, JL; Monge-Monge, D; Asin-Samper, U; Bustamante-Vega, M; Rabago-Lorite, I; Freire-Castro, SJ; Miramontes-Gonzalez, JP; Magallanes-Gamboa, JO; Alcala-Pedrajas, JN; Garcia-Gomez, M; Cano-Llorente, V; Carrasco-Sanchez, FJ; Martinez-Carrilero, J; Anton-Santos, JM; Gomez-Huelgas, R – 2022

Influence of Diagnostic Delay on Survival Rates for Patients with Colorectal Cancer._

Padilla-Ruiz, M; Morales-Suarez-Varela, M; Rivas-Ruiz, F; Alcaide, J; Varela-Moreno, E; Zarcos-Pedrinaci, I; Tellez, T; Fernandez-de Larrea-Baz, N; Bare, M; Bilbao, A; Sarasqueta, C; Aguirre-Larracoechea, U; Quintana, JM; Redondo, M – 2022

Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain_

de Lucas, MDG; Miramontes-Gonzalez, JP; Aviles-Bueno, B; Jimenez-Millan, AI; Rivas-Ruiz, F; Perez-Belmonte, LM – 2022

Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice_

Perez-Belmonte, LM; Sanz-Canovas, J; de Lucas, MDG; Ricci, M; Aviles-Bueno, B; Cobos-Palacios, L; Perez-Velasco, MA; Lopez-Sampalo, A; Bernal-Lopez, MR; Jansen-Chaparro, S; Miramontes-Gonzalez, JP; Gomez-Huelgas, R – 2022

Remdesivir in Very Old Patients (>= 80 Years) Hospitalized with COVID-19: Real World Data from the SEMI-COVID-19 Registry_

Ramos-Rincon, JM; Lopez-Carmona, MD; Cobos-Palacios, L; Lopez-Sampalo, A; Rubio-Rivas, M; Martin-Escalante, MD; De-Cossio-Tejido, S; Taboada-Martinez, ML; Muino-Miguez, A; Areses-Manrique, M; Martinez-Cilleros, C; Tunon-de-Almeida, C; Abella-Vazquez, L; Martinez-Gonzalez, AL; Diez-Garcia, LF; Ripper, CJ; Asensi, V; Martinez-Pascual, A; Guisado-Vasco, P; Lumbreras-Bermejo, C; Gomez-Huelgas, R – 2022

Ultraviolet exposure of competitors during a Tokyo Olympic Sailing Regatta Test Event

Gutierrez-Manzanedo, JV; Pardal, CV; Blazquez-Sanchez, N; De Galvez, MV; Aguilera-Arjona, J; Gonzalez-Montesinos, JL; Ruiz, FR; De Troya-Martin, M – 2022

Machine learning-based model for prediction of clinical deterioration in hospitalized patients by COVID 19

Garcia-Gutierrez, S; Esteban-Aizpiri, C; Lafuente, I; Barrio, I; Quiros, R; Quintana, JM; Uranga, A – 2022

Use of health care services according to functional performance in community-dwelling older adults in Spain. An approach using GAMLSS models.

Mateo-Abad, M; Vrotsou, K; Ruiz, MP; Montiel-Luque, A; Figueredo, MDS; Machon, M; Ruiz, FR; Vergara, I – 2022

Carbohydrate antigen 125 (CA125) as a prognostic marker in the elderly with acute heart failure and preserved ejection fraction

Llacer, P; Nunez, J; Manzano, L; Rodrigo, JMC; Bautista, PS; Garcia, MG; Vila, JCT; Lopez, RQ; Reboiro, MLL; Montero-Perez-Barquero, M – 2022

Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018_

Diaz-Guzman, J; Freixa-Pamias, R; Garcia-Alegria, J; Cabeza, AIP; Roldan-Rabadan, I; Antolin-Fontes, B; Rebollo, P; Llorac, A; Genis-Girones, M; Escobar-Cervantes, C – 2022

« Entradas más antiguas



Miembros

Investigador Responsable
Será Investigador de este nivel los Investigadores Responsable que lideren un grupo de investigación del Instituto y sus Co-IR. Esta categoría puede incluir investigadores muy excepcionales en su disciplina.

José Javier García Alegría

Correo electrónico: jg.alegria@hotmail.com
ORCID
SCOPUS

Investigador Asistencial Colaborador
Será Investigador Asistencial Colaborador el Investigador que no reúne la consideración de Investigador Posdoctoral. Estarán adscritos a un Grupo de Investigación liderado por un IR. Las funciones serán las que le tenga asignada su IR.

Investigadores posdoctorales y/o junior
Será Investigador Asistencial Colaborador el Investigador que no reúne la consideración de Investigador Posdoctoral. Estarán adscritos a un Grupo de Investigación liderado por un IR. Las funciones serán las que le tenga asignada su IR.

ALBERTO JIMÉNEZ PUENTE

Perfil investigador/a: R2

Investigadores predoctorales y/o en formación
Será Investigador Asistencial Colaborador el Investigador que no reúne la consideración de Investigador Posdoctoral. Estarán adscritos a un Grupo de Investigación liderado por un IR. Las funciones serán las que le tenga asignada su IR.

FRANCISCO RIVAS RUIZ

Perfil investigador/a: R1